NCT01895439View on ClinicalTrials.gov

Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

Autologous Mesenchymal Stem Cells

Trial Locations (1)

11942

Cell Therapy Center, Jordan University Hospital, Amman

All Listed Sponsors
lead

University of Jordan

OTHER

NCT01895439 - Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis | Biotech Hunter | Biotech Hunter